95 related articles for article (PubMed ID: 12377963)
1. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Wong RJ; Lin DT; Schöder H; Patel SG; Gonen M; Wolden S; Pfister DG; Shah JP; Larson SM; Kraus DH
J Clin Oncol; 2002 Oct; 20(20):4199-208. PubMed ID: 12377963
[TBL] [Abstract][Full Text] [Related]
2. Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
Yamakawa N; Nakayama Y; Ueda N; Yagyuu T; Tamaki S; Kirita T
Oral Radiol; 2023 Oct; 39(4):668-682. PubMed ID: 37081306
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between non-small cell lung cancer and radiation pneumonitis after carbon-ion radiotherapy by
Suga M; Nishii R; Miwa K; Kamitaka Y; Yamazaki K; Tamura K; Yamamoto N; Kohno R; Kobayashi M; Tanimoto K; Tsuji H; Higashi T
Sci Rep; 2021 Jun; 11(1):11509. PubMed ID: 34075072
[TBL] [Abstract][Full Text] [Related]
4. Correlations between DW-MRI and
Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
[TBL] [Abstract][Full Text] [Related]
5. Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation.
Iovoli AJ; Farrugia MK; Ma SJ; Chan JM; Markiewicz MR; McSpadden R; Wooten KE; Gupta V; Kuriakose MA; Hicks WL; Singh AK
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806792
[TBL] [Abstract][Full Text] [Related]
6. Impact of PET/CT for Assessing Response to Immunotherapy-A Clinical Perspective.
Lang D; Wahl G; Poier N; Graf S; Kiesl D; Lamprecht B; Gabriel M
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33126715
[TBL] [Abstract][Full Text] [Related]
7. Role of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Evaluation of Head and Neck Carcinoma.
Abouzied MM; Fathala A; Alsugair A; Muhaideb AIA; Qahtani MHA
World J Nucl Med; 2017; 16(4):257-265. PubMed ID: 29033672
[TBL] [Abstract][Full Text] [Related]
8. Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.
Folkert MR; Setton J; Apte AP; Grkovski M; Young RJ; Schöder H; Thorstad WL; Lee NY; Deasy JO; Oh JH
Phys Med Biol; 2017 Jul; 62(13):5327-5343. PubMed ID: 28604368
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.
Rosko A; Birkeland A; Shuman A; Prince M; Bradford C; Wolf G; Worden F; Eisbruch A; Srinivasan A; Wong KK; Spector ME
Head Neck; 2017 May; 39(5):980-987. PubMed ID: 28236331
[TBL] [Abstract][Full Text] [Related]
10. Multimodality functional imaging using DW-MRI and
Aramburu Núñez D; Lopez Medina A; Mera Iglesias M; Salvador Gomez F; Dave A; Hatzoglou V; Paudyal R; Calzado A; Deasy JO; Shukla-Dave A; Muñoz VM
World J Radiol; 2017 Jan; 9(1):17-26. PubMed ID: 28144403
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal squamous cell cancer with late presentation of isolated liver metastasis on fluorodeoxyglucose positron emission tomography-computed tomography.
Aksoy SY; Vatankulu B; Halac M; Sönmezoglu K
Indian J Nucl Med; 2016; 31(4):289-291. PubMed ID: 27833316
[TBL] [Abstract][Full Text] [Related]
12. Common patterns of perineural spread in head-neck squamous cell carcinoma identified on fluoro-deoxy-glucose positron emission tomography/computed tomography.
Chandra P; Purandare N; Shah S; Agrawal A; Rangarajan V
Indian J Nucl Med; 2016; 31(4):274-279. PubMed ID: 27833312
[TBL] [Abstract][Full Text] [Related]
13. An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept study.
Padovani L; Baret A; Ciccolini J; Taieb D; Bardia F; Teissonnier L; Muracciole X; Barlesi F; Barbolosi D
Br J Radiol; 2016 Jun; 89(1062):20160061. PubMed ID: 27043244
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.
Manca G; Vanzi E; Rubello D; Giammarile F; Grassetto G; Wong KK; Perkins AC; Colletti PM; Volterrani D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1360-75. PubMed ID: 26780912
[TBL] [Abstract][Full Text] [Related]
15. The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.
Han M; Kim SY; Lee SJ; Choi JW
Medicine (Baltimore); 2015 Nov; 94(47):e2141. PubMed ID: 26632740
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma.
Su M; Zhao L; Wei H; Lin R; Zhang X; Zou C
Strahlenther Onkol; 2015 Aug; 191(8):642-8. PubMed ID: 25981635
[TBL] [Abstract][Full Text] [Related]
18. Role of dual time fluorodeoxyglucose (FDG) positron emission tomography-computed tomography in identifying co-existing inflammatory and malignant disease: Who holds it (FDG) longer?
Nair AV; Sandya CJ; Shagos GS; Anirudh S; Rajamma BM; Ramachandran PV; Moorthy S
Indian J Nucl Med; 2015; 30(2):139-41. PubMed ID: 25829732
[TBL] [Abstract][Full Text] [Related]
19. Emerging biomarkers in head and neck cancer in the era of genomics.
Kang H; Kiess A; Chung CH
Nat Rev Clin Oncol; 2015 Jan; 12(1):11-26. PubMed ID: 25403939
[TBL] [Abstract][Full Text] [Related]
20. PET/CT Is Complementary to Fine-Needle Aspiration Cytology in Assessment of Irradiated Neck in Head and Neck Cancers.
Chan RC; Chan YW
Surg Res Pract; 2014; 2014():191267. PubMed ID: 25374947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
